These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 17376914)

  • 21. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Yang Z; Wood C
    J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.
    Gong D; Dai X; Xiao Y; Du Y; Chapa TJ; Johnson JR; Li X; Krogan NJ; Deng H; Wu TT; Sun R
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.
    Yan Q; Ma X; Shen C; Cao X; Feng N; Qin D; Zeng Y; Zhu J; Gao SJ; Lu C
    J Virol; 2014 May; 88(9):4987-5000. PubMed ID: 24554664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.
    Sun R; Lin SF; Gradoville L; Yuan Y; Zhu F; Miller G
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10866-71. PubMed ID: 9724796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.
    Varthakavi V; Smith RM; Deng H; Sun R; Spearman P
    Virology; 2002 Jun; 297(2):270-80. PubMed ID: 12083825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
    Groves AK; Cotter MA; Subramanian C; Robertson ES
    J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
    Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylation changes at lysine 5 of histone H4 associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus.
    Hwang LR; Cha S; Jong JE; Jang JH; Seo T
    Acta Virol; 2014; 58(3):282-6. PubMed ID: 25283865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
    Cirone M
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
    Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
    Yang M; Huang L; Li X; Kuang E
    Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of the KSHV and EBV lytic cycles to tumourigenesis.
    Manners O; Murphy JC; Coleman A; Hughes DJ; Whitehouse A
    Curr Opin Virol; 2018 Oct; 32():60-70. PubMed ID: 30268927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.